Published in Drug Week, February 16th, 2007
The report "phase IV Clinical Trials: Post-Marketing Study Management Structure, Strategy & Benchmarks" finds that company size influences the outsourcing of phase IV activities.
Of the companies surveyed, only 44% of small companies and 40% of mid-sized companies have the internal infrastructure to support phase IV management. This lack of internal infrastructure...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.